Terapia CAR-T

• Terapia CAR-T
• Análisis de sangre
• Análisis bioquímico de la sangre
• Biopsia
• Tomografía computarizada
• Consulta con un médico
• Consulta con un oncólogo
• Consulta con un hematólogo
• Consulta con un inmunólogo
• Consulta con un hematólogo pediatra
• Hemograma completo con marcadores tumorales y proteinograma
• Angiografía por tomografía computarizada
• Electrocardiograma
• Examen postoperatorio
• TEP/TC
• Biomicroscopía ultrasónica (UBM)
• Ultrasonografía (USG)
• Consulta con un hematólogo oncólogo
• Servicio de enfermería las 24 horas
• 3 comidas diarias preparadas por un nutricionista

• 21 días en el hospital

• Traslado aeropuerto-clínica-aeropuerto

CAR-T Therapy for CLL / Richter’s Transformation at Sheba Medical Center

For patients diagnosed with Chronic Lymphocytic Leukemia (CLL) or Richter’s Transformation, a more aggressive progression of the disease, finding an effective treatment option can be especially challenging.
Sheba Medical Center, one of the world’s leading hospitals, offers advanced CAR-T cell therapy, providing new hope for patients with relapsed or treatment-resistant disease.
Sheba combines cutting-edge immunotherapy with deep expertise in complex hematologic cancers, delivering personalized solutions even in the most aggressive cases.

A Faster Path to Advanced Treatment

At Sheba, the entire CAR-T process is performed on-site, ensuring speed, precision, and optimal cell quality, a critical advantage for patients with rapidly progressing disease.

• Apheresis – collection of the patient’s T-cells
• Cell Engineering – genetic modification at Sheba’s Advanced Biotherapy Center
• Infusion – reinfusion of modified cells designed to identify and destroy cancer cells

By eliminating the need for external laboratories, treatment can begin in approximately 10 days, significantly reducing delays compared to many international centers.
CAR-T therapy acts as a “living therapy,” continuing to work in the body and offering the potential for deep and durable remission, even in aggressive disease forms like Richter’s transformation.
All patients are treated under the leadership of Prof. Arnon Nagler, a globally recognized expert in hemato-oncology.

Advanced Treatment for Complex Cases

CLL and Richter’s transformation often require highly specialized care. At Sheba, hematologists, oncologists, and immunotherapy experts work together to design the most effective, individualized treatment strategy.
CAR-T therapy provides a promising option for patients who have exhausted conventional therapies, offering meaningful clinical responses and improved outcomes in difficult-to-treat cases.

Why Patients Choose Sheba

• Rapid access to CAR-T therapy – treatment initiation in ~10 days
• Extensive experience – one of the leading CAR-T programs in the region
• Dedicated CAR-T units – with 24/7 expert monitoring
• Multidisciplinary expertise – integrated care across specialties
• Full international support – medical review, travel coordination, and patient assistance

Comprehensive, Personalized Care

Each patient undergoes a complete diagnostic evaluation, including advanced imaging, bone marrow biopsy, genetic and molecular testing, and full medical assessment, ensuring a precise, personalized treatment plan.
Services are provided in English, Russian, and Arabic, ensuring a smooth and supportive experience for international patients.

A Leading Center for Advanced Hemato-Oncology Care

By combining innovative CAR-T technology, in-house cell production, and world-class expertise, Sheba delivers one of the most advanced and accessible CAR-T programs for CLL and Richter’s transformation worldwide offering patients a real opportunity for disease control and improved quality of life.

• Coordinador médico personal
• Organización de viajes médicos: reserva de billetes de avión y habitaciones de hotel a precios especiales para socios
• La protección de los intereses de pacientes durante un viaje médico